- Evaluate your small molecule, biologic, or formulation excipients for its potential to lyse red blood cells
- Personalized experimental design to ensure the most relevant data is obtained with the options to examine all relevant in vivo pharmacologically relevant blood from appropriate species
- All assays are performed with high-quality reagents and strict controls by experienced immunologists
Service Overview
About the Hemolysis Assay
We measure in vitro hemolysis by evaluating hemoglobin release as a marker of red blood cell lysis following test agent exposure. Exposure to drugs (biologics or excipients) can cause hemolysis, even in normal adults, potentially resulting in neutropenia, thrombocytopenia, hemolytic anemia, aplastic anemia, and macrocytic anemia. Therefore, according to FDA recommendations, testing for hemolytic potential should be performed.
The iQ Experience
Tailored Experiments
Your research is important to us. Our scientists will work through each step of the process with you, including assay design, data analysis, and recommendations for future studies.
Streamlined Process
Simplify your workflow. Bypass the middle-man: at iQ Biosciences, you'll get immediate access to our biospecimen inventory, saving you both valuable time and money.
Expertise
We're experts- so you don't have to be. Augmenting years of experience in immunology and working with immune assays, our scientists stay current with the latest publications and technology.
Exceptional Service
We're here to help. We know the challenges you're facing: whether it be through expedited service or our complimentary consulting services, our team is dedicated to helping you reach your goals.
